Case Reports in Gastrointestinal Medicine

Case Reports in Gastrointestinal Medicine / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 2474515 | https://doi.org/10.1155/2016/2474515

Manabu Kaneko, Shin Sasaki, Shuzo Teruya, Kosuke Ozaki, Kazuhiro Ishimaru, Emi Terai, Hiroshi Nakayama, Toshiyuki Watanabe, "Pneumatosis Cystoides Intestinalis in Patients with Systemic Sclerosis: A Case Report and Review of 39 Japanese Cases", Case Reports in Gastrointestinal Medicine, vol. 2016, Article ID 2474515, 5 pages, 2016. https://doi.org/10.1155/2016/2474515

Pneumatosis Cystoides Intestinalis in Patients with Systemic Sclerosis: A Case Report and Review of 39 Japanese Cases

Academic Editor: Tetsuo Hirata
Received19 May 2016
Revised16 Jul 2016
Accepted23 Jul 2016
Published29 Aug 2016

Abstract

Pneumatosis cystoides intestinalis (PCI) is a rare gastrointestinal complication of systemic sclerosis (SSc) characterized by intramural accumulation of gas within thin-walled cysts. We report the case of an 82-year-old female patient with pneumoperitoneum due to PCI associated with SSc and review the features of the 39 Japanese cases. The median patient age was 57 years (range 24–83 years) and the male/female ratio was 1 : 12. In the recent decade, 14 out of 15 cases (93.3%) evaluated with CT scans were diagnosed with PCI. The results suggest that CT scan may be a useful diagnostic tool for detecting PCI. PCI in patients with SSc is usually benign and requires only conservative therapy. However, two patients (5.1%) with signs of peritoneal irritation required surgery. When peritoneal irritation secondary to additional pathology is observed, surgical treatment may be warranted; a precise diagnosis for this condition is therefore essential.

1. Introduction

Pneumatosis cystoides intestinalis (PCI) is a rare gastrointestinal complication of systemic sclerosis (SSc). It is characterized by submucosal and/or subserosal collections of free gas, forming cystic lesions within the gastrointestinal tract and neighboring tissues [1, 2]. This complication is usually asymptomatic and detected incidentally through widespread use of computed tomography (CT) in recent years; however, it can be accompanied by abdominal pain and pneumoperitoneum. Clinical presentations and imaging characteristics in this condition may simulate true gastrointestinal perforation. A precise diagnosis is therefore essential, since PCI is generally treated conservatively. An extensive search on PubMed and the Japanese Medical Abstracts Society found 38 Japanese patients diagnosed with PCI accompanied by SSc over a span of 38 years (from 1978 to 2015). We hereby describe a case of SSc complicated by PCI and review the demographic, clinical, diagnostic, and therapeutic features of the 39 Japanese cases.

2. Case Report

An 82-year-old woman was referred to our department for incidental finding of pneumoperitoneum on a chest radiograph during a medical checkup at another hospital. Initial history taking revealed a prior surgical history of only a laparotomy secondary to acute appendicitis approximately 60 years before. During physical examination, the patient was afebrile with a pulse rate of 82 beats per minute and blood pressure of 136/86 mmHg. Abdominal examination revealed a slightly distended but soft, tympanic, and nontender abdomen, without signs of peritoneal irritation. There were no palpable masses. Urgent laboratory investigations showed a slightly low hemoglobin level with normal white blood cell count and C-reactive protein level (Table 1). A plain abdominal radiograph showed free air under the diaphragm bilaterally and small bowel dilatation (Figure 1). Abdominal CT scan revealed massive free air and dilated small intestine with gas inside the bowel wall; however, there was no radiological evidence of a localized point of bowel obstruction and no apparent life-threatening acute causes of PCI (Figure 2). Although autoimmune serological testing showed negative results for antinuclear, anti-Scl-70, and anticentromere antibodies, further detailed history taking revealed that the patient had suffered from Raynaud’s phenomenon and was previously diagnosed with SSc approximately 30 years before. She recalled that she was treated and followed up for several years, albeit without detailed information regarding her treatment. A rheumatologist later confirmed that she indeed had limited cutaneous SSc, in view of the presence of sclerodactyly of the fingers, telangiectasia on her face, chest, and hands, and Raynaud’s phenomenon, all of which met the criteria for SSc [3]. Her pneumoperitoneum was considered to be due to PCI. As the patient was stable with no life-threatening signs and symptoms, she was treated conservatively with bowel rest and maintenance of fluid levels and subsequently discharged home without surgical intervention. The patient remained well eighteen months after discharge, without any abdominal symptoms.


⁢Complete blood count⁢Blood chemistry⁢Autoantibody (normal value)

WBC4800/μLTP7.4 g/dLAntinuclear (speckled)1 : 40 (<×40)
RBC/μLAlb3.9 g/dLAnti-Scl-708.9 (<10)
Hemoglobin10.3 g/dLBUN20.8 mg/dLAnticentromere<5.0 (<10)
Hematocrit32.1%Cre1.0 mg/dL
Platelet/μLNa143 mEq/L
K4.4 mEq/L
Cl111 mEq/L
T-Bil0.4 mg/dL
AST20 IU/L
ALT12 IU/L
LDH166 IU/L
γ-GTP9 IU/L
CRP0.00 mg/dL
 HbA1c5.4%

WBC: white blood cell; RBC: red blood cell; TP: total protein; Alb: albumin; BUN: blood urea nitrogen; Cre: creatinine; T-Bil: total bilirubin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; γ-GTP: γ-glutamyl transferase; CRP: C-reactive protein; Na: sodium; K: potassium; Cl: chloride; HbA1c: glycated hemoglobin.

3. Discussion

PCI is a rare gastrointestinal complication of SSc characterized by intramural accumulation of gas within thin-walled cysts. Air-filled bubble-like lesions are located in the submucosa or the subserosa of the alimentary tract. Although PCI is most commonly seen in the small intestine, it can also be detected in the large intestine or the stomach [2]. When these air-filled cysts rupture, they cause a pneumoperitoneum, which is generally benign in nature.

We searched on PubMed and the Japanese Medical Abstracts Society for case reports, excluding brief reports on clinical images, containing the key words “pneumatosis cystoides intestinalis” and “systemic sclerosis or scleroderma”. Of note, 39 cases from Japan (including our case) have been reported in the literature. Of these, 35 cases were reported in Japanese, while the others were in English [46] (Table 2). Any symptom that was not described was presumed to be absent. Likewise, any test that was not mentioned was presumed to have not been done. The median patient age was 57 years (range 24–83 years) and the male/female ratio was 1 : 12. Of these, 11 patients (28.2%) had SSc of the diffuse type while 23 (59.0%) had the limited type. The remaining 5 patients (12.8%) had types that could not be assessed. The mean disease duration from onset of SSc symptoms to diagnosis of PCI was 6 years (range 0–30 years). Antinuclear, anticentromere, and anti-Scl-70 antibodies were positive in 33, 7, and 3 patients (84.6%, 18.0%, and 7.7%), respectively. Overlap syndrome was seen in 8 patients with polymyositis (20.5%) and 1 patient with Sjogren’s syndrome (2.6%). Small intestinal PCI was detected in 29 patients (74.3%) and large intestinal PCI in 4 patients (10.2%). The symptoms observed, in decreasing order, were abdominal distention (, 82.1%), abdominal pain (, 33.3%), abdominal tenderness (, 28.2%), and nausea or vomiting (, 23.1%), among others. Peritoneal irritation was seen in two patients (5.1%), both of whom required surgery. Pneumoperitoneum was involved in 34 patients (87.2%).


CharacteristicsNumber of patients

Age (years), median (range)57 (24–83)
Sex
 Female36 (92.3%)
 Male3 (7.7%)
Types of scleroderma
 Diffuse11 (28.2%)
 Limited23 (59.0%)
 NA5 (12.8%)
Duration from onset of SSc to onset of PCI (years), median (range)6 (0–30)
Past corticosteroid therapy
 Present24 (61.5%)
Autoantibody positivity
 Antinuclear antibody33 (84.6%)
 Anticentromere antibody7 (18.0%)
 Anti-Scl-70 antibody3 (7.7%)
 Negative6 (15.4%)
Overlap syndrome
 Polymyositis/scleroderma8 (20.5%)
 Sjogren’s syndrome/scleroderma1 (2.6%)
Site of PCI
 Small intestine27 (69.2%)
 Small and large intestine2 (5.1%)
 Large intestine2 (5.1%)
 NA8 (20.5%)
Symptoms and signs
 Abdominal distention32 (82.1%)
 Abdominal pain13 (33.3%)
 Abdominal tenderness11 (28.2%)
 Nausea/vomiting9 (23.1%)
 Weight loss8 (20.5%)
 Anorexia8 (20.5%)
 Constipation5 (12.8%)
 Fatigue5 (12.8%)
 Diarrhea5 (12.8%)
 Peritoneal irritation sign2 (5.1%)
Diagnostic modalities
 Upper gastrointestinal series2 (5.1%)
 Plain X-ray film10 (25.6%)
 CT11 (28.2%)
 Plain X-ray film and CT11 (28.2%)
 Exploratory laparotomy5 (12.8%)
Pneumoperitoneum
 Present34 (87.2%)
 Absent5 (12.8%)
Treatment
 Antibiotics13 (33.3%)
 Oxygen therapy9 (23.1%)
 Octreotide2 (5.1%)
 Surgery2 (5.1%)
 Treatments other than the above-mentioned ones (symptomatic therapy combined with fluid therapy or elemental diet, etc.)15 (38.5%)

SSc: systemic sclerosis; PCI: pneumatosis cystoides intestinalis; NA: not available; CT: computed tomography.

Gastrointestinal manifestation in SSc is characterized by atrophy of the muscularis propria and its replacement by collagen tissue, resulting in disturbances of digestive peristalsis and leading to gastroparesis, bacterial overgrowth of the small intestine, or constipation [7]. The etiology of PCI in patients with SSc is not fully understood. However, there are several possible mechanisms of how gas cysts were produced in the bowel wall. The mechanical theory suggests that increased luminal pressure caused by intestinal obstruction allows gas to penetrate into the submucosal space through a mucosal breakdown [8]. The bacterial theory suggests that gas cysts result from either excess hydrogen gas produced by intraluminal bacterial fermentation or altered partial pressure of nitrogen within the intestinal wall [9]. Finally, it has been advocated that long term use of corticosteroids could possibly induce atrophy of the intestinal mucosa, sometimes resulting in a mucosal break and the subsequent translocation of gas into the submucosal layer [10, 11]. In this review, 24 patients (61.5%) were reported to have received corticosteroid therapy.

PCI may be detected through a variety of different radiographic imaging modalities, such as plain radiographs, contrast studies, CT scan, ultrasound, and magnetic resonance imaging. Among these, CT scan is the best diagnostic modality, with better sensitivity than plain radiographs or ultrasound [12]. In actual clinical settings, CT scan should follow a plain radiograph film with suggestive findings such as radiolucent linear or circular air bubbles in the bowel wall with/without subdiaphragmatic free air. In addition, a CT scan can provide additional information that may suggest the existence of other causes of PCI, such as intestinal volvulus, necrosis, or perforation [7]. In this review, CT scan was reported to be useful for detection of PCI in 22 (56.4%) cases. In the recent decade, particularly, 14 out of 15 cases (93.3%) evaluated with CT scans were diagnosed with PCI.

Treatment of PCI should be based on symptoms; in other words, patients with asymptomatic PCI need no treatment. If there are symptoms, excluding peritoneal irritation, conservative treatment, including one or more of the following, may be initiated: fluid and electrolyte supplementation, total parenteral nutrition, bowel rest, bowel tract decompression, elemental diet, antibiotics (tetracycline, metronidazole, or ampicillin), high concentration or hyperbaric oxygen inhalation therapy, and octreotide infusion [1316]. Antibiotics are used for small intestinal bacterial overgrowth [17]. The bacterial theory is supported by the observation that benign PCI often responds to dietary changes, antibiotic therapy, and oxygen, which is believed to attenuate the gaseous cysts by decreasing the partial pressure of the nitrogenous gases and by being toxic to the anaerobic gut bacteria [9, 1821]. In this review, the number of patients who received antibiotics, high concentration oxygen therapy, and hyperbaric oxygen therapy was 13 (33.3%), 7 (17.9%), and 2 (5.1%), respectively. Fifteen patients (38.5%) received other treatments such as fluid therapy, bowel tract decompression, or elemental diet. In our case, the patient did not exhibit any signs of peritonitis or bowel ischemia; therefore, conservative management was selected. Surgical treatment is generally not preferred because the disease is almost always generalized, and operative manipulation of a scleroderma bowel tends to result in prolonged ileus [13]. However, emergency surgical exploration must be taken into consideration when the clinical presentation, laboratory results, or imaging tests indicate peritoneal irritation [22]. In this review, two patients (5.1%) with signs of peritoneal irritation required surgery: one for small bowel volvulus and the other for recurrent peritonitis due to inflammation of the dilated jejunal loops resulting from distal jejunal stricture.

In conclusion, PCI among SSc patients is a rare complication, and its pathology is still not fully understood. In most cases, conservative management is preferable to surgical intervention. However, when peritoneal irritation is observed, surgical treatment may be warranted; a precise diagnosis is therefore essential in deciding whether a patient should be subjected to extensive surgery or treated conservatively. CT scan is a useful diagnostic tool for detecting not only PCI, but also additional pathology.

Written informed consent was obtained from the patient for publication.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contributions

All authors contributed equally to this paper.

References

  1. V. Suarez, I. M. Chesner, A. B. Price, and J. Newman, “Pneumatosis cystoides intestinalis. Histological mucosal changes mimicking inflammatory bowel diseae,” Archives of Pathology and Laboratory Medicine, vol. 113, no. 8, pp. 898–901, 1989. View at: Google Scholar
  2. W. Sequeira, “Pneumatosis cystoides intestinalis in systemic sclerosis and other diseases,” Seminars in Arthritis and Rheumatism, vol. 19, no. 5, pp. 269–277, 1990. View at: Publisher Site | Google Scholar
  3. F. Van Den Hoogen, D. Khanna, J. Fransen et al., “2013 classification criteria for systemic sclerosis: an american college of rheumatology/European league against rheumatism collaborative initiative,” Arthritis and Rheumatism, vol. 65, no. 11, pp. 2737–2747, 2013. View at: Publisher Site | Google Scholar
  4. T. Kobayashi, M. Kobayashi, M. Naka, K. Nakajima, A. Momose, and M. Toi, “Response to octreotide of intestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis,” Internal Medicine, vol. 32, no. 7, pp. 607–609, 1993. View at: Publisher Site | Google Scholar
  5. M. Hamada, M. Kayashima, Y. Morai, T. C. Masuda, K. Urabe, and M. Furue, “Pneumatosis cystoides intestinalis with systemic sclerosis, limited type resulting in a poor prognosis,” American Journal of the Medical Sciences, vol. 332, no. 2, pp. 100–102, 2006. View at: Publisher Site | Google Scholar
  6. A. Sagara, K. Kitagawa, K. Furuichi et al., “Three cases of pneumatosis intestinalis presenting in autoimmune diseases,” Modern Rheumatology, vol. 22, no. 4, pp. 610–615, 2012. View at: Publisher Site | Google Scholar
  7. L. M. Ho, E. K. Paulson, and W. M. Thompson, “Pneumatosis intestinal is in the adult: benign to life-threatening causes,” American Journal of Roentgenology, vol. 188, no. 6, pp. 1604–1613, 2007. View at: Publisher Site | Google Scholar
  8. A. S. Pieterse, A. S.-Y. Leong, and R. Rowland, “The mucosal changes and pathogenesis of pneumatosis cystoides intestinalis,” Human Pathology, vol. 16, no. 7, pp. 683–688, 1985. View at: Publisher Site | Google Scholar
  9. M. D. Levitt and S. Olsson, “Pneumatosis cystoides intestinalis and high breath H2 excretion: insights into the role of H2 in this condition,” Gastroenterology, vol. 108, no. 5, pp. 1560–1565, 1995. View at: Publisher Site | Google Scholar
  10. B. H. Smith and L. H. Welter, “Pneumatosis intestinalis,” American Journal of Clinical Pathology, vol. 48, no. 5, pp. 455–465, 1967. View at: Publisher Site | Google Scholar
  11. R. R. Hall, A. Anagnostou, M. Kanojia, and A. Zander, “Pneumatosis intestinalis associated with graft-versus-host disease of the intestinal tract,” Transplantation Proceedings, vol. 16, no. 6, pp. 1666–1668, 1984. View at: Google Scholar
  12. S. D. St Peter, M. A. Abbas, and K. A. Kelly, “The spectrum of pneumatosis intestinalis,” Archives of Surgery, vol. 138, no. 1, pp. 68–75, 2003. View at: Publisher Site | Google Scholar
  13. G. Lock, A. Holstege, B. Lang, and J. Schölmerich, “Gastrointestinal manifestations of progressive systemic sclerosis,” The American Journal of Gastroenterology, vol. 92, no. 5, pp. 763–771, 1997. View at: Google Scholar
  14. E. C. Ebert, “Gastric and enteric involvement in progressive systemic sclerosis,” Journal of Clinical Gastroenterology, vol. 42, no. 1, pp. 5–12, 2008. View at: Publisher Site | Google Scholar
  15. J. Vischio, Z. Matlyuk-Urman, and S. Lakshminarayanan, “Benign spontaneous pneumoperitoneum in systemic sclerosis,” Journal of Clinical Rheumatology, vol. 16, no. 8, pp. 379–381, 2010. View at: Publisher Site | Google Scholar
  16. A. Balbir-Gurman, O. R. Brook, I. Chermesh, and Y. Braun-Moscovici, “Pneumatosis cystoides intestinalis in scleroderma-related conditions,” Internal Medicine Journal, vol. 42, no. 3, pp. 323–329, 2012. View at: Publisher Site | Google Scholar
  17. G. Gyger and M. Baron, “Systemic sclerosis: gastrointestinal disease and its management,” Rheumatic Disease Clinics of North America, vol. 41, no. 3, pp. 459–473, 2015. View at: Publisher Site | Google Scholar
  18. C. E. Yale, E. Balish, and J. P. Wu, “The bacterial etiology of pneumatosis cystoides intestinalis,” Archives of Surgery, vol. 109, no. 1, pp. 89–94, 1974. View at: Publisher Site | Google Scholar
  19. R. Reyna, R. T. Soper, and R. E. Condon, “Pneumatosis intestinalis. Report of twelve cases,” The American Journal of Surgery, vol. 125, no. 6, pp. 667–671, 1973. View at: Publisher Site | Google Scholar
  20. N. W. Read, M. N. Al-Janabi, and P. A. Cann, “Is raised breath hydrogen related to the pathogenesis of pneumatosis coli?” Gut, vol. 25, no. 8, pp. 839–845, 1984. View at: Publisher Site | Google Scholar
  21. T. Florin and B. Hills, “Does counterperfusion supersaturation cause gas cysts in pneumatosis cystoides coli, and can breathing heliox reduce them?” The Lancet, vol. 345, no. 8959, pp. 1220–1222, 1995. View at: Publisher Site | Google Scholar
  22. P. N. Khalil, S. Huber-Wagner, R. Ladurner et al., “Natural history, clinical pattern, and surgical considerations of pneumatosis intestinalis,” European Journal of Medical Research, vol. 14, no. 6, pp. 231–239, 2009. View at: Publisher Site | Google Scholar

Copyright © 2016 Manabu Kaneko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views802
Downloads367
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.